Tobacco Use Disorder Clinical Trial
Official title:
Self-determination and Maintaining Tobacco Abstinence
These two studies will examine the role of autonomous motivation in maintained adherence. The first study will determine whether smokers are still abstinent from tobacco 32 months after starting in a previous project (Smoker's Health Study). The purpose of the second study is to determine which of three treatments for tobacco dependence provides the greatest amount of protection from relapsing to smoking after quitting. Specifically, the investigators will determine if extending the length of treatment time focusing on relapse prevention and arranging for support from important others prevents relapse compared to community care. Also, the investigators will determine if providing extended treatment time and support from important others plus providing medications to those that don't want to quit prevents long term relapse compared to just extending the length of treatment time and support from others. Additionally, a sub set of the population will be randomized to using hand held palm devices to recover real-time data assessment during the last 10 months of the project.
These two studies will extend our examination of self-determination theory (SDT) based
counseling interventions to the issue of maintained abstinence from tobacco use. Two
projects are proposed, both of which build on the results of our current trial. The first is
a 32-month follow-up of the smoking status of patients in the preceding trial called the
Smoker's Health Study (self-determination, smoking, diet, and health). That SDT intervention
(4 counselor visits over 6 months) increased cessation at 6 months relative to community
care, and was also effective in increasing 12 month prolonged abstinence, and the results
have been reported in two manuscripts (Williams, McGregor, Sharp, Levesque, Kouides, Ryan,
and Deci, In press; Williams, McGregor, Sharp, Levesque, Kouides, Ryan, and Deci, 2005). The
part of this first project that will be conducted as part of this grant will be to complete
32 month follow-up of smokers in the Smoker's Health Study. The second project is a 3-cell
clinical trial called the Smoker's Health Project that will examine two extensions of the
current intervention, both of which place greater emphasis on use of, and adherence to,
cessation medications. The two arms will be compared to community care. Both arms involve
two visits with a physician to discuss medications and side effects. In both interventions,
counselors will address medication adherence. The two arms differ in that patients not ready
to quit in one arm will receive a smoking reduction approach (with medications) in which
they first try to reduce their smoking to half and then attempt cessation. In addition, to
place greater emphasis on medications and to examine medication adherence as a mediator of
maintained cessation.
There will be two major changes in the intervention intended to facilitate long-term
maintenance. First, the intervention will extend over 12 months (whereas the current one
lasts only 6 months) with meetings during the additional 6 months focusing on maintenance
and relapse prevention. Second, at least one family member or best friend of each patient
will be encouraged to meet with a counselor to learn how to be more autonomy supportive with
the patient around issues related to tobacco. Cessation and maintained abstinence will be
examined with logistic regression. The SDT process model of maintained cessation will be
tested using structural equation modeling, and cost-effectiveness analyses will be done for
the interventions.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02432066 -
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
|
Phase 2 | |
Completed |
NCT03960138 -
Examining the Effects of Neural Stimulation on Inhibitory Control and Cigarette Smoking
|
N/A | |
Recruiting |
NCT05030272 -
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
|
N/A | |
Completed |
NCT04646668 -
Comparative Abuse Liability Among African American and White Smokers
|
N/A | |
Completed |
NCT02560324 -
Effect of Ramelteon on Smoking Abstinence
|
Phase 2 | |
Completed |
NCT02347605 -
Medicinal Nicotine for Preventing Cue Induced Craving
|
N/A | |
Completed |
NCT01442753 -
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT01428310 -
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
|
Phase 1 | |
Completed |
NCT01625767 -
Tobacco Approach Avoidance Training for Adolescent Smokers-1
|
Phase 2 | |
Terminated |
NCT01800500 -
Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
|
N/A | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01337817 -
A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers
|
Phase 1 | |
Completed |
NCT00967005 -
N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers
|
Phase 2 | |
Active, not recruiting |
NCT00751660 -
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
|
N/A | |
Completed |
NCT00790569 -
Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
|
N/A | |
Completed |
NCT00664261 -
Clinical Effort Against Secondhand Smoke (CEASE) Program or Standard Care in Helping Parents Stop Smoking
|
N/A | |
Completed |
NCT00158158 -
Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2
|
Phase 2/Phase 3 | |
Completed |
NCT00134927 -
A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches
|
N/A | |
Completed |
NCT00158145 -
Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2
|
Phase 2 |